Can Probiotics Help Combat Obesity in Dogs? Exploring the Role of Gut Microbiota in Weight Management

Obesity has become an increasingly common health concern in companion animal practice, particularly among urban pet populations. Beyond visible weight gain, obesity in dogs is associated with chronic inflammation, impaired mobility, cardiovascular strain, metabolic disturbances, and reduced quality of life¹. 

Traditionally, obesity management has focused on calorie restriction and exercise. However, growing evidence suggests that the intestinal microbiota may also influence body weight regulation and metabolic health^1,2. This has generated interest in probiotics as supportive tools in canine weight management strategies. 

The Link Between Gut Microbiota and Obesity 

The gut microbiota plays a major role in nutrient metabolism, digestion, immune regulation, and energy balance³. Research has demonstrated clear differences between the gut microbial composition of lean and obese animals, with obese dogs often showing reduced bacterial diversity^1,2,4. 

Obesity-related dysbiosis may contribute to: 

• Altered fat metabolism  

• Increased systemic inflammation  

• Reduced metabolic efficiency  

• Hormonal imbalance  

• Gastrointestinal dysfunction¹ 

Reduced serotonin levels have also been observed in obese dogs. Since serotonin influences gastrointestinal motility, decreased levels may slow intestinal transit time, increasing fermentation of undigested carbohydrates and fats and further altering microbial balance^1,2. 

How Probiotics May Support Weight Management 

Probiotics may help address obesity-associated dysbiosis by restoring beneficial microbial populations and improving metabolic function. 

Several probiotic strains investigated in obese dogs have shown promising effects on: 

• Body condition score (BCS)  

• Lipid metabolism  

• Inflammatory activity  

• Glucose regulation  

• Gastrointestinal function^1,4 

Among these, Lactobacillus gasseri BNR17 has attracted attention for its reported ability to reduce body fat accumulation in different animal models². 

Clinical Findings from Probiotic Studies 

Research involving Bifidobacterium lactis IDCC 4301 and Enterococcus faecium IDCC 2102 demonstrated reductions in lipid accumulation and weight gain in obese dogs receiving high-fat diets⁴. 

Supplemented dogs showed several beneficial effects, including: 

• Reduced systemic inflammation  

• Improved glucose metabolism  

• Enhanced pyruvate metabolism  

• Increased beneficial bacterial populations  

• Improved digestion and reduced diarrhea^1,4  

Importantly, these probiotics also influenced short-chain fatty acid production, which may help improve glycolysis and ATP generation within the gut environment⁴. 

Another study evaluating a probiotic combination containing Bifidobacterium breve CBT BR3 and Lactiplantibacillus plantarum CBT LP3 found significant reductions in body weight and BCS without notable adverse effects such as vomiting or diarrhea⁵. 

These findings suggest that microbiota modulation may become a supportive component of obesity management in dogs. 

Broader Metabolic Benefits 

The effects of obesity extend beyond fat accumulation alone. Obese dogs often exhibit altered lipid profiles similar to those observed in humans, including increased triglycerides, total cholesterol, and LDL levels⁶. 

Research has shown that probiotic supplementation may contribute to improvements in liver-associated enzymes such as: 

• Aspartate aminotransferase (AST)  

• Alanine aminotransferase (ALT)  

• Gamma-glutamyl transferase (GGT)⁶ 

This is particularly important because gut microbiota influences communication between the intestine and organs such as the liver, heart, kidneys, and brain. 

Practical Considerations in Veterinary Practice 

While probiotics alone are unlikely to replace dietary management and exercise programs, they may serve as supportive tools in obese dogs with: 

• Poor digestive efficiency  

• Chronic inflammation  

• Recurrent gastrointestinal disturbances  

• Metabolic dysfunction  

Veterinarians should remember that probiotic effects are strain-dependent and influenced by dosage and treatment duration¹. 

Body condition scoring, dietary assessment, and monitoring of metabolic parameters remain essential components of obesity management. 

Conclusion 

The growing understanding of the gut microbiome has expanded perspectives on canine obesity beyond simple caloric imbalance. Research suggests that intestinal microbial diversity and metabolic signaling may influence body weight, inflammation, and overall metabolic health in dogs. 

Although probiotics are not standalone weight-loss therapies, selected strains may help improve microbial balance, support metabolism, and complement conventional obesity management strategies. As microbiome research continues to evolve, probiotics may become increasingly relevant in comprehensive canine weight management programs. 

Reference 

1. Karukayil Gopalakrishnan N, Pappuswamy M, Meganathan G, Shanmugam S, Pushparaj K, Balasubramanian B, Kim IH. Influence of probiotic administration in canine feed: a comprehensive review. Veterinary Sciences. 2025 May 7;12(5):449. https://www.mdpi.com/2306-7381/12/5/449 

2. Lee HJ, Cho JH, Cho WJ, Gang SH, Park SH, Jung BJ, Kim HB, Song KH. Effects of synbiotic preparation containing Lactobacillus gasseri BNR17 on body fat in obese dogs: A pilot study. Animals. 2022 Mar 3;12(5):642. https://www.mdpi.com/2076-2615/12/5/642 

3. Sivamaruthi BS, Kesika P, Chaiyasut C. Influence of probiotic supplementation on health status of the dogs: A review. Applied Sciences. 2021 Dec 1;11(23):11384. https://www.mdpi.com/2076-3417/11/23/11384 

4. Kang A, Kwak MJ, Lee DJ, Lee JJ, Kim MK, Song M, Lee M, Yang J, Oh S, Kim Y. Dietary supplementation with probiotics promotes weight loss by reshaping the gut microbiome and energy metabolism in obese dogs. Microbiology Spectrum. 2024 Mar 5;12(3):e02552-23. https://journals.asm.org/doi/pdf/10.1128/spectrum.02552-23 

5. Choi J, Son D, An S, Cho E, Lim S, Lee HJ. Effects of Lactiplantibacillus plantarum CBT LP3 and Bifidobacterium breve CBT BR3 supplementation on weight loss and gut microbiota of overweight dogs. Scientific Reports. 2024 Oct 26;14(1):25446. https://www.nature.com/articles/s41598-024-75594-9.pdf 

6. Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. International journal of molecular sciences. 2019 Jan 17;20(2):395. https://www.mdpi.com/1422-0067/20/2/395